Free Trial

BioSig Technologies 4/15/2025 Earnings Report

BioSig Technologies logo
$0.58 -0.02 (-4.10%)
Closing price 04/11/2025 03:59 PM Eastern
Extended Trading
$0.59 +0.01 (+2.03%)
As of 04/11/2025 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BioSig Technologies EPS Results

Actual EPS
N/A
Consensus EPS
-$0.17
Beat/Miss
N/A
One Year Ago EPS
N/A

BioSig Technologies Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

BioSig Technologies Announcement Details

Quarter
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Remove Ads

BioSig Technologies Earnings Headlines

BioSig Technologies Delays Form 10-K Filing
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth.
BioSig Technologies confirms full compliance with Nasdaq requirements
See More BioSig Technologies Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like BioSig Technologies? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BioSig Technologies and other key companies, straight to your email.

About BioSig Technologies

BioSig Technologies (NASDAQ:BSGM), together with its subsidiaries, a medical device company, engages in development and commercialization of advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias in the United States. It offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with Mayo Foundation to develop an AI- and machine learning-powered software for PURE EP system. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.

View BioSig Technologies Profile

More Earnings Resources from MarketBeat